Search

everythinglearnresearchcommunity

for

Search:↓

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

FGF-5 promotes Cashmere goat hair growth by increasing keratin genes and reducing certain LncRNA and target genes.

The human K5 promoter controls specific gene expression in skin cells, with key regulatory elements near the TATA box.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

WNT5A contributes to keloid scars by promoting cell changes through specific signaling pathways.

Knocking out the FGF5 gene in sheep increased wool production and hair-follicle density.

STAT5 activation is crucial for starting the hair growth phase.

The OVOL1 gene, controlled by β-catenin, is crucial for creating hair follicles.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

Type 2 5α-reductase plays a key role in hair loss.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

The PIP5K1A gene helps cashmere growth in goats by promoting cell proliferation, and melatonin boosts its expression.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

The mK6irs1/Krt2-6g gene likely causes wavy hair in mice.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Severe CCCA may be biologically and clinically different from milder forms.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Targeting the TNFRSF1B gene may help treat hair loss.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.